Eden Research Signs Agreement To Extend Portfolio to Key Markets
24 September 2015 Eden Research plc, which provides natural microencapsulation technologies to the global agrochemicals industry, has signed agreement with Intellectual Ventures’ Invention Development Fund, that will strengthen and expand Eden’s intellectual property portfolio and provide the company access to Intellectual Venture’s IP-related services and network of licensing and business development professionals.
Under the Agreement, IDF’s will add value to Eden’s IP portfolio and access to key regions around the world with a particular emphasis on Asian, North American, and South American markets. Eden and IDF will collaborate on the sourcing and development of next-generation technologies for the agricultural, animal health, food ingredients, human health and personal care markets. Eden and IDF will also pursue licensing opportunities from IDF’s substantial patent portfolio to support Eden’s current and future business.
“By partnering with IDF we are helping to ensure that our partners receive the full benefits of access to Eden’s technologies which are supported by a comprehensive and secure global patent portfolio,” said Sean Smith, Eden’s CEO. “Eden will utilize IDF’s unique “invention engine” to enhance and extend our core intellectual property portfolio and expand our technology base in areas outside of our current focus. IDF’s global presence will also help us to increase our market presence outside Europe more efficiently and rapidly. IV is one of the world’s largest patent owners and is considered the global leader in monetizing intellectual property assets. As a technology development and licensing company, the benefits of such a partnership are clear.”
Get The Newsletter Today!
